[1]. Quiroz RV, et al. The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer. J Med Chem. 2021 Apr 8;64(7):3911-3939.